Inhibition of G protein-coupled receptor trafficking in neuroblastoma cells by MAP 4 decoration of microtubules

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 6 52-6, 2002, Pages

  Cheng, Guangmao ^a   Iijima, Yoshihiro ^b   Ishibashi, Yuji ^a   Kuppuswamy, Dhandapani ^b   Cooper IV, George ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MUSC Medical Center   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Gene transfer techniques; Microtubule associated proteins; Muscarinic receptors; Radioligand assay

Indexed keywords

CARBACHOL; G PROTEIN COUPLED RECEPTOR; MEMBRANE RECEPTOR; MICROTUBULE ASSOCIATED PROTEIN 4; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; STRUCTURAL PROTEIN;

ADENOVIRUS; AGONIST; ANIMAL CELL; ARTICLE; CELL STIMULATION; DOWN REGULATION; GENE TRANSFER; HEART VENTRICLE HYPERTROPHY; HYPOTHESIS; INHIBITION KINETICS; INTERNALIZATION; MICROTUBULE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY;

EID: 0036889539     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00410.2002     Document Type: Article

References (36)

1. Allan VJ and Schroer TA. Membrane motors. Curr Opin Cell Biol 11: 476-482, 1999.
2. Brodde OE and Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51: 651-689, 1999.
3. Brodde OE, Michel MC, and Zerkowski HR. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res 30: 570-584, 1995.
4. Bulinski JC, McGraw TE, Gruber D, Nguyen HL, and Sheetz MP. Overexpression of MAP 4 inhibits organelle motility and trafficking in vivo. J Cell Sci 110: 3055-3064, 1997.
5. Bünemann M, Lee KB, Pals-Rylaarsdam R, Roseberry AG, and Hosey MM. Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu Rev Physiol 61: 169-192, 1999.
6. Burgermeister W, Klein WL, Nirenberg M, and Witkop B. Comparative binding studies with cholinergic ligands and histrionicotoxin at muscarinic receptors of neural cell lines. Mol Pharmacol 14: 751-767, 1978.
7. Caron M, Andersson A, and Alling C. Effects of ethanol on phosphoinositide hydrolysis and muscarinic acetylcholine receptor number in SH-SY5Y cells. Life Sci 67: 447-456, 2000.
8. Chapin SJ, Lue CM, Yu MT, and Bulinski JC. Differential expression of alternatively spliced forms of MAP 4: A repertoire of structurally different microtubule-binding domains. Biochemistry 34: 2289-2301, 1995.
9. Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, and Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70: 4805-4810, 1996.
10. Cooper G. Cardiocyte cytoskeleton in hypertrophied myocardium. Heart Fail Rev 5: 187-201, 2000.
11. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow EM, and Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease. J Cell Biol 143: 777-794, 1998.
12. Ferguson SSG and Caron MG. G protein-coupled receptor adaptation mechanisms. Semin Cell Dev Biol 9: 119-127, 1998.
13. Hamm-Alvarez SF and Sheetz MP. Microtubule-dependent vesicle transport: Modulation of channel and transporter activity in liver and kidney. Physiol Rev 78: 1109-1129, 1998.
14. Harden TK, Evans T, Hepler JR, Hughes AR, Martin MW, Meeker RB, Smith MM, and Tanner LI. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors. Adv Cyclic Nucleotide Protein Phosphorylation Res 19: 207-220, 1985.
15. Hirokawa N. Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol 6: 74-81, 1994.
16. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279: 519-526, 1998.
17. Koenig JA and Edwardson JM. Intracellular trafficking of the muscarinic acetylcholine receptor: Importance of subtype and cell type. Mol Pharmacol 49: 351-359, 1996.
18. 125I-epidermal growth factor internalization. J Biol Chem 264: 3357-3363, 1989.
19. Lenz W, Petrusch C, Jakobs KH, and van Koppen CJ. Agonist-induced down-regulation of the m4 muscarinic acetylcholine receptor occurs without changes in receptor mRNA steady-state levels. Naunyn Schmiedebergs Arch Pharmacol 350: 507-513, 1994.
20. Liles WC and Nathanson NM. Alteration in the regulation of neuronal muscarinic acetylcholine receptor number induced by chronic lithium in neuroblastoma cells. Brain Res 439: 88-94, 1988.
21. Limas CJ and Limas C. Involvement of microtubules in the isoproterenol-induced down-regulation of myocardial β-adrenergic receptors. Biochim Biophys Acta 735: 181-184, 1983.
22. 3 muscarinic receptors induces phosphorylation of the Cdc42 effector activated Cdc42Hs-associated kinase-1 via a Fyn tyrosine kinase signaling pathway. J Biol Chem 276: 5622-5628, 2001.
23. Olmsted JB and Lyon HD. A microtubule-associated protein specific to differentiated neuroblastoma cells. J Biol Chem 256: 3507-3511, 1981.
24. Olson KR, McIntosh JR, and Olmsted JB. Analysis of MAP 4 function in living cells using green fluorescent protein (GFP) chimeras. J Cell Biol 130: 639-650, 1995.
25. Ostlund RE, Leung JT, and Hajek SV. Biochemical determination of tubulin-microtubule equilibrium in cultured cells. Anal Biochem 96: 155-164, 1979.
26. Post SR, Hammond HK, and Insel PA. β-Adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol 39: 343-360, 1999.
27. Ray P, Middleton W, and Berman JD. Mechanism of agonist-induced down-regulation and subsequent recovery of muscarinic acetylcholine receptors in a clonal neuroblastoma x glioma hybrid cell line. J Neurochem 52: 402-409, 1989.
28. Richelson E. The use of cultured cells in the study of mood-normalizing drugs. Pharmacol Toxicol 66, Suppl 3: 69-75, 1990.
29. Saghir AN, Tuxworth WJ, Hagedorn CH, and McDermott PJ. Modifications of eukaryotic initiation factor 4F (eIF4F) in adult cardiocytes by adenoviral gene transfer: Differential effects on eIF4F activity and total protein synthesis rates. Biochem J 356: 557-566, 2001.
30. Sato H, Nagai T, Kuppuswamy D, Narishige T, Koide M, Menick DR, and Cooper G. Microtubule stabilization in pressure overload cardiac hypertrophy. J Cell Biol 139: 963-973, 1997.
31. 2 muscarinic acetylcholine receptor. J Biol Chem 275: 23295-23302, 2000.
32. Shifrin GS and Klein WL. Regulation of muscarinic acetylcholine receptor concentration in cloned neuroblastoma cells. J Neurochem 34: 993-999, 1980.
33. Trinczek B, Ebneth A, Mandelkow EM, and Mandelkow E. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci 112: 2355-2367, 1999.
34. Tsutsui H, Ishihara K, and Cooper G. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science 260: 682-687, 1993.
35. Yabe JT, Pimenta A, and Shea TB. Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J Cell Sci 112: 3799-3814, 1999.
36. Zaslaver A, Feniger-Barish R, and Ben-Baruch A. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2. J Immunol 166: 1272-1284, 2001.